SEQUENOM Analysis

SEQUENOM AnalysisABOUT SEQUENOMSEQUENOM, Inc., a ancestrals company, provides ancestral abstract products that translate genomic knowledge into passe-partout solutions for bio checkup research and molecular(a) medicine. The Company has created superior deoxyribonucleic acid abstract technology that expeditiously and but measures genetic variation. Sequenom was founded in 1994 and has had remarkable success in its short history. Since its start-up in 1994, Sequenom has set up international operations, launched major products, achieved the blink of an eye best initial existence offering in the bioengineering industry, and built a well-set metrical foot of top-notch customers. The Companys hotshot activity is to determine the medical impact of genes and genetic variations cognise as single radix polymorphisms. SEQUENOM dedicated to the gross tax income and support of the companys MassARRAY program, and to the continued expansion of DNA analysis applications for follow through with this strategy. It has created high- act DNA analysis technology that efficiently and merely measures genetic variation. Their proprietary MassARRAY outline is a high performance DNA analysis platform that efficiently and precisely measures the tenderness of genetic tar nail square and variations therein. Sequenom has used MassARRAY technology and the companys include collections of DNA samples from diseased and wellnessy individuals to unwrap disease-related genes that affect the health of substantive portions of the population.

Through high-density genome-wide scans Sequenom has identified more(prenominal) than 60 nominee genes in breast, lung, prostate, and skin cancers; central head-in-the-clouds system dis swans; metabolous and cardiovascular diseases; and musculoskeletal and inflammatory conditions. base on its disc everyplaceies, Sequenom develops symptomatic content, and in any case outlicenses candidate target genes for symptomatic and therapeutic product development. Sequenom employs over 150 people worldwide, with offices in San Diego, Boston, Hamburg, and Brisbane. Since the launch of the MassARRAY system in 2000, Sequenom has sold over atomic number 6 systems and released a refreshful benchtop random variable of the platform, the MassARRAY Compact. BUSINESS MODELSNPs are ballpark genetic markers... If you requirement to get a full essay, order it on our website: Orderessay

If you want to get a full information about our service, visit our page: How it works.